Serious Adverse Event Reporting Explained: Ultimate Guide to Clinical Trial Safety and Compliance Mastering Serious Adverse Event Reporting: Compliance-Ready Guide for Global Clinical Trials Introduction to Serious Adverse Event Reporting and Its Importance Serious Adverse Event (SAE) reporting is one of the most critical compliance obligations in clinical trials. Regulators including the FDA, EMA, and CDSCO mandate immediate and accurate reporting of SAEs to protect participant safety and ensure ethical conduct. An SAE is defined as any untoward medical occurrence that results in death, is life-threatening, requires hospitalization, causes disability, or leads to congenital anomaly. Proper SAE reporting helps regulators…